To highlight the critical function of DCAF15 in the mechanism of action of indisulam against T-ALL, we employed CRISPR-Cas9 technology to generate DCAF15-null variants in both the J. gamma1 and Jurkat cell models. The gene discussed is DCAF15; the disease is acute lymphoblastic leukemia.